Assura (LON:AGR)‘s stock had its “add” rating reissued by analysts at Numis Securities in a research note issued to investors on Tuesday, Analyst Price Targets reports. They presently have a GBX 88 ($1.15) price objective on the real estate investment trust’s stock. Numis Securities’ target price suggests a potential upside of 20.38% from the company’s previous close.
Separately, Jefferies Financial Group increased their target price on shares of Assura from GBX 87 ($1.14) to GBX 90 ($1.18) and gave the company a “buy” rating in a research report on Wednesday, February 17th. Five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Assura has an average rating of “Hold” and an average target price of GBX 83.83 ($1.10).
LON:AGR traded up GBX 0.65 ($0.01) during midday trading on Tuesday, reaching GBX 73.10 ($0.96). 5,655,586 shares of the stock traded hands, compared to its average volume of 5,954,729. Assura has a 12-month low of GBX 70 ($0.91) and a 12-month high of GBX 86.27 ($1.13). The business has a 50-day moving average of GBX 73.48 and a two-hundred day moving average of GBX 74.38. The company has a debt-to-equity ratio of 71.01, a quick ratio of 5.36 and a current ratio of 5.37. The stock has a market capitalization of £1.96 billion and a PE ratio of 21.50.
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities.
Read More: What is a Special Dividend?
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.